The protective effects of angiotensin-converting enzyme inhibitor against cecal ligation and puncture-induced sepsis via oxidative stress and inflammation.
Angiotensin-Converting Enzyme Inhibitors
/ pharmacology
Animals
Anti-Inflammatory Agents, Non-Steroidal
/ pharmacology
Cecum
/ surgery
Extracellular Vesicles
/ drug effects
Female
Glutathione
/ metabolism
Inflammation
/ drug therapy
Lung
/ drug effects
Oxidative Stress
/ drug effects
Perindopril
/ pharmacology
Protective Agents
/ pharmacology
Punctures
/ adverse effects
Rats, Sprague-Dawley
Sepsis
/ etiology
Tumor Necrosis Factor-alpha
/ metabolism
Cecal ligation and puncture
Inflammation
Lung
Oxidative stress
Perindopril
Rat
Sepsis
Journal
Life sciences
ISSN: 1879-0631
Titre abrégé: Life Sci
Pays: Netherlands
ID NLM: 0375521
Informations de publication
Date de publication:
15 Jan 2020
15 Jan 2020
Historique:
received:
04
09
2019
revised:
06
11
2019
accepted:
07
11
2019
pubmed:
17
11
2019
medline:
7
2
2020
entrez:
17
11
2019
Statut:
ppublish
Résumé
Sepsis is a severe public health problem affecting millions of individuals, with global mortality rates caused by lower respiratory tract infections are approximately 2.38 million people a year die from respiratory failure caused by infection. Although ACE is known to contribute to damage in septicemia, the pathophysiological mechanisms of sepsis remain unclear. While mortality can be significantly reduced through effective and sensitive antibiotic therapy, antibiotic resistance restricts the use of these drugs, and the investigation of novel agents and targets is therefore essential. Our aim was to determine whether Perindopril (PER) has anti-inflammatory and antioxidant capable of preventing these adverse conditions resulting in injury in previous studies. Sprague Dawley rats were randomly assigned into the control group, received oral saline solution alone for four days. the cecal ligation and puncture (CLP) group, underwent only cecal ligation and puncture induced sepsis, while the CLP + PER (2 mg/kg) underwent cecal ligation and puncture-induced sepsis together with oral administration of 2 mg/kg PER for four days before induction of sepsis. Malondialdehyde (MDA), tumor necrosis factor-alpha (TNF-α), Caspase-3 and nuclear factor kappa B (NF-kβ/p65) levels increased in the CLP group. On the other hand, PER (2 mg/kg) oral administration to septic rats decreased MDA, TNF-α and increase glutathione (GSH) in the lung tissue. In addition, PER administration also decreased the lung tissue NF-κB and Caspase-3 immunopositivity against sepsis. PER treatment may represent a promising means of preventing sepsis-induced lung injury via antioxidant and anti-inflammation effects.
Identifiants
pubmed: 31733315
pii: S0024-3205(19)30978-6
doi: 10.1016/j.lfs.2019.117051
pii:
doi:
Substances chimiques
Angiotensin-Converting Enzyme Inhibitors
0
Anti-Inflammatory Agents, Non-Steroidal
0
Protective Agents
0
Tumor Necrosis Factor-alpha
0
Glutathione
GAN16C9B8O
Perindopril
Y5GMK36KGY
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
117051Informations de copyright
Copyright © 2019 Elsevier Inc. All rights reserved.